Choong-wae wins US patent for Wnt target anticancer agent

Published: 2009-09-23 06:58:00
Updated: 2009-09-23 06:58:00
Choong-wae Pharm said on September 18 it recently won the U.S. substance patent for the building-block molecules of Wnt target anticancer drug (code name: CWP231A).

“We have a plan to explore overseas markets for with licensing-out strategies,” said a senior company official.

The firm is no...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.